Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6brd1

Behavioural Brain Research

Volumn 206, Issue 1, 2010, Pages 52-62

  Costa, Alberto C S ^a,b   Stasko, Melissa R ^a   Schmidt, Cecilia ^c   Davisson, Muriel T ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

Aneuploidy; Down syndrome; Fear conditioning; Morris water maze; Mouse models; Trisomy 16; Trisomy 21; Ts65Dn mice

Indexed keywords

PHOSPHODIESTERASE VI;

ANEUPLOIDY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BLINDNESS; BODY HEIGHT; BODY WEIGHT; BREEDING; CONDITIONING; CONTROLLED STUDY; DOWN SYNDROME; FEAR; GENE MUTATION; GRIP STRENGTH; LOCOMOTION; MAZE TEST; MOTOR DYSFUNCTION; MOUSE; MOUSE STRAIN; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROGENY; RETINA DEGENERATION; SUPERNUMERARY CHROMOSOME; TASK PERFORMANCE; TS65DN MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY SIZE; BODY WEIGHT; CONDITIONING, CLASSICAL; DISEASE MODELS, ANIMAL; DOWN SYNDROME; EXPLORATORY BEHAVIOR; FEAR; HAND STRENGTH; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; PHENOTYPE; SPATIAL BEHAVIOR;

EID: 70350211447     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.08.034     Document Type: Article

References (51)

1. Davisson M.T., Schmidt C., and Akeson E.C. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 360 (1990) 263-280
2. Sago H., Carlson E.J., Smith D.J., Kilbridge J., Rubin E.M., Mobley W.C., et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 95 (1998) 6256-6261
3. Olson L.E., Richtsmeier J.T., Leszl J., and Reeves R.H. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306 (2004) 687-690
4. O'Doherty A., Ruf S., Mulligan C., Hildreth V., Errington M.L., Cooke S., et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309 (2005) 2033-2037
5. Li Z., Yu T., Morishima M., Pao A., Laduca J., Conroy J., et al. Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 16 (2007) 1359-1366
6. Davisson M.T., and Costa A.C.S. Mouse models of Down syndrome. Adv Neurochem 9 (1999) 297-327
7. Patterson D., and Costa A.C. Down syndrome and genetics-a case of linked histories. Nat Rev Genet 6 (2005) 137-147
8. Sérégaza Z., Roubertoux P.L., Jamon M., and Soumireu-Mourat B. Mouse models of cognitive disorders in trisomy 21: a review. Behav Genet 36 (2006) 387-404
9. Rachidi M., and Lopes C. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. Eur J Paediatr Neurol 12 (2008) 168-182
10. Williams A.D., Mjaatvedt C.H., and Moore C.S. Characterization of the cardiac phenotype in neonatal Ts65Dn mice. Dev Dyn 237 (2008) 426-435
11. Pennington B.F., Moon J., Edgin J., Stedron J., and Nadel L. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev 74 (2003) 75-93
12. Baxter L.L., Moran T.H., Richtsmeier J.T., Troncoso J., and Reeves R.H. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9 (2000) 195-202
13. Bouwknecht J.A., and Paylor R. Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav Pharmacol 19 (2008) 385-402
14. Schalken J.J., Janssen J.J., Sanyal S., Hawkins R.K., and de Grip W.J. Development and degeneration of retina in rds mutant mice: immunoassay of the rod visual pigment rhodopsin. Biochim Biophys Acta 1033 (1990) 103-109
15. Liu D.P., Schmidt C., Billings T., and Davisson M.T. Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome. Biotechniques 35 (2003) 1170-1174
16. Bowes C., Li T., Frankel W.N., Danciger M., Coffin J.M., Applebury M.L., et al. Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase. Proc Natl Acad Sci USA 90 (1993) 2955-2959
17. Stasko M.R., and Costa A.C. Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome. Behav Brain Res 154 (2004) 1-17
18. Dineley K.T., Xia X., Bui D., Sweatt J.D., and Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 277 (2002) 22768-22780
19. Sananbenesi F., Fischer A., Schrick C., Spiess J., and Radulovic J. Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1. Mol Cell Neurosci 21 (2002) 463-476
20. Blanchard R.J., and Blanchard D.C. Crouching as an index of fear. J Comp Physiol Psychol 67 (1969) 370-375
21. Bolles R.C., and Riley A.L. Freezing as an avoidance response: another look at the operant-respondent distinction. Learn Motiv 4 (1973) 268-275
22. Meyer O.A., Tilson H.A., Byrd W.C., and Riley M.T. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1 (1979) 233-236
23. Costa A.C., Walsh K., and Davisson M.T. Motor dysfunction in a mouse model for Down syndrome. Physiol Behav 68 (1999) 211-220
24. Escorihuela R.M., Fernández-Teruel A., Vallina I.F., Baamonde C., Lumbreras M.A., Dierssen M., et al. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett 199 (1995) 143-146
25. Escorihuela R.M., Vallina I.F., Martinez-Cue C., Baamonde C., Dierssen M., Tobena A., et al. Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome. Neurosci Lett 247 (1998) 171-174
26. Reeves R.H., Irving N.G., Moran T., Wohn A., Sissodia S.S., Schmidt C., et al. A mouse model for Down syndrome exhibits learning and behavior deficits. Nat Genet 11 (1995) 177-184
27. Holtzman D.M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D.J., Daniels S.E., et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93 (1996) 13333-13338
28. Sago H., Carlson E.J., Smith D.J., Rubin E.M., Crnic L.S., Huang T.T., et al. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res 48 (2000) 606-613
29. Martinez-Cue C., Baamonde C., Lumbreras M., Paz J., Davisson M.T., Schmidt C., et al. Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome. Behav Brain Res 134 (2002) 185-200
30. Martinez-Cue C., Rueda N., Garcia E., Davisson M.T., Schmidt C., and Florez J. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome. Behav Brain Res 163 (2005) 174-185
31. Moran T.H., Capone G.T., Knipp S., Davisson M.T., Reeves R.H., and Gearhart J.D. The effects of piracetam on cognitive performance in a mouse model of Down's syndrome. Physiol Behav 77 (2002) 403-409
32. Olson L.E., Roper R.J., Sengstaken C.L., Peterson E.A., Aquino V., Galdzicki Z., et al. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet 16 (2007) 774-782
33. Rueda N., Flórez J., and Martínez-Cué C. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Neurosci Lett 433 (2008) 22-27
34. Rueda N., Flórez J., and Martínez-Cué C. Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome. Behav Brain Res 188 (2008) 355-367
35. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
36. Logue S.F., Paylor R., and Wehner J.M. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned fear task. Behav Neurosci 111 (1997) 104-113
37. Costa A.C., Scott-McKean J.J., and Stasko M.R. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Neuropsychopharmacology 33 (2008) 1624-1632
38. Hyde L.A., Frisone D.F., and Crnic L.S. Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. Behav Brain Res 118 (2001) 53-60
39. Turner C.A., Presti M.F., Newman H.A., Bugenhagen P., Crnic L., and Lewis M.H. Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behav Genet 31 (2001) 393-400
40. Blanchard D.C., and Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol 81 (1972) 281-290
41. Blanchard D.C., Blanchard R.J., Lee E.M.C., and Fukunaga K.K. Movement arrest and the hippocampus. Physiol Psychol 5 (1977) 331-335
42. Phillips R.G., and LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106 (1992) 274-285
43. Maren S. Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur J Neurosci 28 (2008) 1661-1666
44. Goosens K.A., and Maren S. Pretraining NMDA receptor blockade in the basolateral complex, but not the central nucleus, of the amygdala prevents savings of conditional fear. Behav Neurosci 117 (2003) 738-750
45. Hampton T.G., Stasko M.R., Kale A., Amende I., and Costa A.C.S. Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome. Physiol Behav 82 (2004) 381-389
46. Fernandez F., Morishita W., Zuniga E., Nguyen J., Blank M., Malenka R.C., et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 10 (2007) 411-413
47. Hunter C.L., Bimonte H.A., and Granholm A.C. Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory. Behav Brain Res 138 (2003) 121-131
48. Clark S., Schwalbe J., Stasko M.R., Yarowsky P.J., and Costa A.C. Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome. Exp Neurol 200 (2006) 256-261
49. Bianchi P, Ciani E, Contestabile A, Guidi S, Bartesaghi R. Lithium Restores Neurogenesis in the Subventricular Zone of the Ts65Dn Mouse, a Model for Down Syndrome. Brain Pathol; in press.
50. Lockrow J., Prakasam A., Huang P., Bimonte-Nelson H., Sambamurti K., and Granholm A.C. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol 216 (2009) 278-289
51. Vink J., Incerti M., Toso L., Roberson R., Abebe D., and Spong C.Y. Prenatal NAP+SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-d-aspartic acid and gamma-aminobutyric acid receptors. Am J Obstet Gynecol (2009) 200 524.e1-4